Eris Lifesciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA4395110
EBIT3964460
Earning Per Share262928
Expenses7818621,148
Net Profit355406374
Net Profit Margin293022
Operating Profit Margin363833
Profit Before Tax394442405
Dividends Per Share660
Operation Revenue1,2211,3731,696

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
202300377.40NA868.45
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Eris Lifesciences is 0 as of 6/8/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities235223271375378
Investing Activities-590-5123-323-320
Financing Activities363-221-335-82-45
Others00000
Net Cash Flow8-360-3014

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20201,392.41-783.52-444.66164.23
20201,468.841,106.99-890.581,685.25
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Eris Lifesciences is 378 as of 6/8/2023